Tesla’s Stock Skyrockets on AI Hype – Latest Price Jump, Earnings Shocks & Bold 2025 Forecasts

Tesla (TSLA) premarket today — Nov 7, 2025: Musk’s $1T pay wins approval; China FSD timeline, ‘terafab’ chip plan, and what to watch before the bell

Published: November 7, 2025


Key takeaways

  • TSLA is indicating higher before the open. As of 4:05 a.m. ET, Tesla traded around $453.81 in premarket, about +1.8% vs. Thursday’s close of $445.91. Shares also firmed to $452.93 in after-hours on Thursday. Premarket indications can change quickly. [1]
  • Shareholders approved Elon Musk’s record pay package. A new $1 trillion performance award passed with over 75% support at Thursday’s annual meeting in Austin. The plan is tied to aggressive targets (including valuation, robotaxis and humanoid robots). [2]
  • China FSD timing: Musk said he expects full approval of Full Self‑Driving (FSD) in China early 2026 (following partial approval this year). [3]
  • AI chips & capacity: Musk floated building a “gigantic chip fab” for Tesla’s next‑gen AI chips and said it’s “worth having discussions” with Intel on manufacturing. [4]
  • Macro risk at 8:30 a.m. ET: The U.S. Employment Situation (October) lands 60 minutes before the opening bell—often a major factor for high‑beta names like TSLA. CPI for October is due next Thursday (Nov 13). [5]

Premarket snapshot: price, context, tone

Tesla closed Thursday at $445.91 (-3.5%) after a choppy session, then firmed to $452.93 after hours and is pointing higher before today’s open around $453.81. The modest bid coincides with shareholders’ approval of Musk’s new compensation plan and optimism around Tesla’s AI/robotics roadmap. (Prices are delayed; premarket quotes are indicative.) [6]


The news moving TSLA this morning

1) Shareholders approve Musk’s $1T package

Investors gave Elon Musk a fresh, performance‑based compensation plan that could be worth up to $1 trillion over the next decade if Tesla meets sweeping milestones. Multiple outlets report more than 75% of votes were cast in favor. The plan sharpens Tesla’s pivot from a pure EV story toward AI, robotaxis (“Cybercab”), humanoid robots (Optimus) and energy/compute at massive scale. [7]

Why it matters:

  • The vote reduces near‑term uncertainty over Musk’s commitment and influence at Tesla.
  • Governance debate isn’t going away, but bulls see the approval as clearing a path for the AI/robotics valuation narrative to stay front‑and‑center. [8]

2) China FSD: full approval “early 2026”

Musk told shareholders he expects full regulatory approval for FSD in China in February–March 2026, after partial approval earlier this year. China remains Tesla’s most strategically vital overseas market; broader FSD availability there would open new software revenue and data advantages. [9]

3) Musk floats a Tesla “terafab” for AI chips; open to Intel discussions

At the meeting, Musk said Tesla likely needs a “gigantic chip fab” to build its AI5 (and beyond) inference/training chips at volume, adding it’s “worth having discussions” with Intel on manufacturing. He also referenced TSMC and Samsung as ongoing partners. A home‑grown chip ramp could ease dependence on third‑party supply and sharpen Tesla’s AI margins over time—execution and capex will be the swing factors. [10]

4) Product roadmap notes from the meeting

Coverage of the event highlighted timelines Musk reiterated or teased: Cybercab (robotaxi) production targeted for April 2026, the next‑gen Roadster unveiling in April 2026, and plans to scale Optimus. Timelines remain ambitious and conditional on regulatory and manufacturing readiness. [11]


Today’s market setup: what matters before the bell

  • Jobs report (8:30 a.m. ET): The October Employment Situation can sway yields and high‑beta tech. A “hot” print tends to lift rates and weigh on long‑duration growth stocks; a “cool” print can do the opposite. Keep an eye on the two‑year and 10‑year Treasury moves into the open. CPI (Oct) follows on Thursday, Nov 13—another macro catalyst for risk appetite. [12]
  • Positioning into weekly expiry:Nov‑7 weekly TSLA options show heavy interest in near‑the‑money calls (e.g., $450–$455 strikes appearing among the morning’s most active contracts), underscoring a trader focus on a post‑vote pop and macro‑headline volatility. (Options activity is dynamic; check live screens.) [13]

How to frame TSLA right now

Bull case this morning: Governance overhang eases; China FSD path gets a clearer timeline; AI chip capacity plans reinforce the “physical AI” thesis (robotaxis, humanoids, energy + software). If the jobs report is benign and yields stay contained, the backdrop could support a bid in high‑beta mega caps—TSLA included. [14]

Bear case / Risks: Execution remains enormous—regulatory approvals (especially for Cybercab/FSD in multiple jurisdictions), capex intensity for chips and robotics, and a still‑competitive global EV market. The governance debate isn’t settled for skeptics; some large institutions remain critical of concentration of power and dilution concerns. Macro (jobs/CPI) can quickly overwhelm single‑name narratives intraday. [15]


By the numbers (as you head into the open)

  • Thursday close:$445.91
  • After‑hours (Thu):$452.93 (~+1.6% vs. close)
  • Premarket (Fri ~4:05 a.m. ET):$453.81 (~+1.8% vs. close)
    (All quotes delayed; premarket levels move rapidly.) [16]

Bottom line

Going into the Nov 7 open, TSLA is trading the post‑vote narrative: Musk stays, AI/robotics push intensifies, China FSD timeline firmed up, and chip capacity ambitions escalate. Near‑term price action likely pivots on the 8:30 a.m. ET jobs report and whether broader risk sentiment cooperates. For now, the tape points modestly higher as bulls try to lean into the newly re‑centered AI + autonomy story. [17]


Disclosure: This article is for news and informational purposes only and does not constitute investment advice. Always do your own research and consider your risk tolerance before trading or investing.

The Biggest Week in Tesla Stock's History... (WATCH ASAP)

References

1. www.marketwatch.com, 2. www.reuters.com, 3. www.reuters.com, 4. www.reuters.com, 5. www.bls.gov, 6. www.marketwatch.com, 7. www.reuters.com, 8. www.businessinsider.com, 9. www.reuters.com, 10. www.reuters.com, 11. www.investors.com, 12. www.bls.gov, 13. www.nasdaq.com, 14. www.reuters.com, 15. www.businessinsider.com, 16. www.marketwatch.com, 17. www.reuters.com

Stock Market Today

  • GoPro Q3 2025: Wider Loss, Sharp Revenue Decline, New Hardware Aims to Rebound
    November 7, 2025, 12:49 PM EST. GoPro (GPRO) reported Q3 2025 results with a non-GAAP loss per share of $0.09, wider than the Zacks consensus of a $0.03 loss. The company also guided a non-GAAP adjusted loss of $0.04 +/- $0.02 for the quarter, after breaking even a year ago. Revenue was $162.9 million, down 37.1% YoY, versus a guided range of $160 million +/- $10 million and beating estimates by about 0.5%. Three new hardware products-MAX2 360, LIT HERO, and Fluid Pro AI gimbal-aim to expand the TAM, with expectations to return to growth and profitability in Q4 2025 and into 2026. Units sold: 500,000 (−18% YoY); GoPro.com revenue $40 million (−22%), subscriptions $27 million (−3%), with 2.42 million subscribers.
  • 4 Must-Buy Efficient Stocks to Enrich Your 2025 Portfolio
    November 7, 2025, 12:40 PM EST. Using Efficiency Ratios-Receivables Turnover, Asset Utilization, Inventory Turnover, and Operating Margin-along with a Zacks Rank #1 (Strong Buy) filter, the screen narrowed 7,906 stocks to 11. The top four stocks through the screen are Indivior (INDV), Proto Labs (PRLB), Las Vegas Sands (LVS), and Oceaneering International (OII). These names show strong cash collection, asset efficiency, lean inventory, and controlled operating costs, signaling potential upside for 2025. Investors should assess current industry norms and market conditions before acting.
  • Chipotle Slumps 25% in a Month: Is the Selloff Creating a Buy Opportunity?
    November 7, 2025, 12:34 PM EST. Chipotle Mexican Grill CMG has shed roughly 25% in the last month as investors weigh signs of slowing traffic among younger and lower-income diners. In the period, the broader market fared better-industry peers and the S&P 500 posted mixed to modest declines/gains. Management cited a 0.3% rise in third-quarter comparable sales, driven by a decline in transactions as households tighten budgets. The 25-35 age cohort remains a pressure point, and Chipotle's decision not to pursue aggressive menu-price hikes has kept sentiment cautious. Yet the company preserves core fundamentals, including strong new-unit economics, a resilient digital loyalty platform, and ongoing menu innovation. If transaction trends improve with operational and marketing initiatives, the pullback could verify a value opportunity for long-term investors, not a structural breakdown.
  • 5 Dividend Growth Stocks to Weather Volatility: VRT, TPR, HCA, LRCX, CBOE
    November 7, 2025, 12:32 PM EST. Amid a volatile market and tech-led sell-off, investors may favor dividend growth stocks over high-yield plays. Companies with a history of raising payouts often display strong financial health and can act as a defensive hedge. The piece spotlights Vertiv (VRT), Tapestry (TPR), HCA Healthcare (HCA), Lam Research (LRCX) and CBOE Global Markets (CBOE) as examples of durable dividend growth. Key filters include positive 5-year dividend growth, expanding sales and EPS, and Next 3-5 Year EPS Growth. Additional metrics look for Price/Cash Flow below industry peers and a 52-Week Price Change outperforming the S&P 500. Yields may be modest, but these firms offer upside potential and resilience in uncertain times.
  • Tilray Brands Soars 94.5% in 3 Months: Buy, Sell, or Hold?
    November 7, 2025, 12:30 PM EST. Tilray Brands (TLRY) has jumped 94.5% over the last quarter, outpacing an industry that slipped about 2.5%. The rally followed a CNBC report on potential federal rules for hemp products and hints that a Trump administration could ease marijuana restrictions, plus Tilray's Q1 results showing record net revenues of $210 million and a strengthened balance sheet. The company is expanding its Tilray Medical footprint globally, including the Solana Life Group venture in Panama, new EU products from Germany, and a strategic Italy partnership with Molteni. In Australia, it launched its first medical cannabis edible. On the bottom line, Q1 net income rose to $1.5 million from a year-ago loss, with adjusted net income of $3.9 million as costs were disciplined. Zacks pegs 2026 sales up about 6.8%, with earnings guidance still evolving.
Saudi Aramco Stock Analysis 2025: Is the Oil Giant Still Worth Your Money?
Previous Story

Saudi Aramco (2222.SR) — Before Market Open Today (Nov 7, 2025): Oil Rebounds But Heads for Weekly Loss, Aramco Cuts Asian OSPs, and Q3 Dividend Dates to Watch

Meta’s AI Revolution Unleashed: July 2025 Breakthroughs, Billion‑Dollar Bets & Backlash
Next Story

Meta Platforms (META) Pre‑Market Update Today — November 7, 2025: Reuters scam‑ads bombshell, fresh AI‑training lawsuit, and what it means for the stock

Go toTop